Literature DB >> 11704972

Pharmaceutical regulation: the early experience of the NHS National Institute for Clinical Excellence (NICE) appraisal process--where are we headed?

R Taylor1.   

Abstract

Mesh：

Year:  2001        PMID： 11704972     DOI： 10.1046/j.1524-4733.2001.004001008.x

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

1.  Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat?

Authors:  Rod S Taylor; John Hutton; Anthony J Culyer
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Establishing multiple omics baselines for three Southeast Asian populations in the Singapore Integrative Omics Study.

Authors:  Woei-Yuh Saw; Erwin Tantoso; Husna Begum; Lihan Zhou; Ruiyang Zou; Cheng He; Sze Ling Chan; Linda Wei-Lin Tan; Lai-Ping Wong; Wenting Xu; Don Kyin Nwe Moong; Yenly Lim; Bowen Li; Nisha Esakimuthu Pillai; Trevor A Peterson; Tomasz Bielawny; Peter J Meikle; Piyushkumar A Mundra; Wei-Yen Lim; Ma Luo; Kee-Seng Chia; Rick Twee-Hee Ong; Liam R Brunham; Chiea-Chuen Khor; Heng Phon Too; Richie Soong; Markus R Wenk; Peter Little; Yik-Ying Teo
Journal:  Nat Commun       Date:  2017-09-21       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.